|
|
Article: Essential Therapeutics Reports ETRX 101 Results.
- Article from:
- PR Newswire
- Article date:
- January 6, 2003
|
Copyright informationCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Essential Therapeutics, Inc. today announced that it has completed its Phase I trial for ETRX 101, and that based upon its review of the Phase I data and the data from recently completed non-clinical studies, the Company has decided not to continue the development of ETRX 101. The Company indicated that neither the Phase I data nor the non-clinical data generated by the Company showed signs of sufficient efficacy to support the continuation of development of ETRX 101 as a single agent. "We are obviously disappointed with the results of the ETRX 101 Phase I study and the non-clinical results we have received," said Mark Skaletsky, President and Chief Executive Officer of ...
Related newspaper, magazine, and journal articles:
|
|
Article: A BIG GUN IN TOUGH SPOT
The Boston Globe;
February 13, 2003 ;
635 words
......current start-up project, Essential Therapeutics Inc. in Waltham. Recent...make you feel queasy. Essential Therapeutics stock would have been...company, now renamed Essential Therapeutics, in the form of preferred...
|
|